These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20104701)

  • 21. Renal effects of angiotensin-I converting enzyme inhibitors.
    Gans RO; Hoorntje SJ; Donker AJ
    Neth J Med; 1988 Jun; 32(5-6):247-64. PubMed ID: 3292962
    [No Abstract]   [Full Text] [Related]  

  • 22. [The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension].
    Klaus D
    Z Kardiol; 1988; 77 Suppl 3():73-88. PubMed ID: 3062960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
    Reams GP; Singh A; Logan KW; Holmes RA; Bauer JH
    J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of atherosclerotic renal artery stenosis. Low dosage ACE inhibitors and angiotensin-receptor blockers are justified in certain cases].
    Alhadad A; Sterner G; Herlitz H
    Lakartidningen; 2009 Oct 28-Nov 3; 106(44):2836-8, 2840. PubMed ID: 19967962
    [No Abstract]   [Full Text] [Related]  

  • 25. [Uses of angiotensin converting enzyme inhibitor in kidney diseases].
    Xu XW; Wang HY
    Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):122-4. PubMed ID: 7767767
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hypertensive patients have to be doubly treated earlier. Which antihypertensive drug combination is appropriate to whom?].
    MMW Fortschr Med; 2003 May; 145(22):56. PubMed ID: 12866285
    [No Abstract]   [Full Text] [Related]  

  • 27. [Percutaneous intravascular balloon dilatation of the renal arteries as a method of treating renovascular hypertension].
    Kukharchuk VV; Arabidze GG
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):112-5. PubMed ID: 6222747
    [No Abstract]   [Full Text] [Related]  

  • 28. Enhancement of screening tests for renovascular hypertension by angiotensin-converting enzyme inhibition.
    Jonker GJ; Huisman RM; de Zeeuw D
    Nephrol Dial Transplant; 1993; 8(9):798-807. PubMed ID: 8255511
    [No Abstract]   [Full Text] [Related]  

  • 29. Renovascular hypertension: current concepts.
    Garovic V; Textor SC
    Semin Nephrol; 2005 Jul; 25(4):261-71. PubMed ID: 16202699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Jan; 14(2):5-7. PubMed ID: 12776699
    [No Abstract]   [Full Text] [Related]  

  • 31. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Krut LH
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12846227
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypertension guidelines and goals of treatment: role of calcium antagonists.
    Hansson L
    Int J Clin Pract Suppl; 2000 Nov; (114):41-4. PubMed ID: 11221294
    [No Abstract]   [Full Text] [Related]  

  • 33. [Policy of antihypertensive therapy in arterial hypertension in the elderly. II].
    Gurevich MA
    Klin Med (Mosk); 2002; 80(9):9-13. PubMed ID: 12416217
    [No Abstract]   [Full Text] [Related]  

  • 34. Renal artery stenosis: pathophysiology and treatment.
    Gottam N; Nanjundappa A; Dieter RS
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1413-20. PubMed ID: 19900024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal hemodynamics, converting enzyme inhibitors and calcium antagonists in atheromatous renovascular hypertension.
    Hannedouche T; Godin M; Fillastre JP
    Clin Nephrol; 1987 Nov; 28(5):261-2. PubMed ID: 3427836
    [No Abstract]   [Full Text] [Related]  

  • 36. Advances in the medical management of renovascular hypertension.
    Vidt DG
    Urol Clin North Am; 1984 Aug; 11(3):417-24. PubMed ID: 6087531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deterioration of renal function after converting enzyme inhibition in a patient with renal artery stenosis after transplantation.
    Van Son WJ; Donker AJ; Van der Woude FJ; Meijer S; Slooff MJ; Tegzess AM; Van der Slikke LB
    Neth J Med; 1984; 27(1):10-3. PubMed ID: 6324009
    [No Abstract]   [Full Text] [Related]  

  • 38. [Usefulness of converting enzyme inhibitors in the diagnosis of arterial hypertension].
    Arnal JF
    Rev Prat; 1992 Dec; 42(20):2551-6. PubMed ID: 1299939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renovascular hypertension.
    Little C
    Am J Nurs; 2000 Feb; 100(2):46-51; quiz 52. PubMed ID: 10683643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.